WCN24-2088 Increased eryptosis and inflammatory cytokines are associated with low hemoglobin levels in hemodialysis patients

Renal anemia is prevalent at some point in time in most hemodialysis (HD) patients. In addition to absolute or relative erythropoietin deficiency, research suggests premature red blood cell (RBC) death (eryptosis) and inflammation are key pathogenetic factors. However, a comprehensive understanding of the interplay between eryptosis, hemoglobin (Hb) levels, and the concentration of inflammatory mediators is still missing. Our goal was to explore the relationship between eryptosis and cytokine levels with Hb levels in hemodialysis (HD) patients.